Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
116 hedge funds and large institutions have $660M invested in Flexion Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 34 increasing their positions, 33 reducing their positions, and 8 closing their positions.
213% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 8
24% more capital invested
Capital invested by funds: $532M → $660M (+$128M)
16% more funds holding
Funds holding: 100 → 116 (+16)
14% more call options, than puts
Call options by funds: $14.2M | Put options by funds: $12.5M
3% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 33
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$15.4M |
| 2 |
GS
Gagnon Securities
New York
|
+$3.39M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$3.1M |
| 4 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
+$2.91M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$2.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$7.18M |
| 2 |
ZDA
Zweig-DiMenna Associates
New York
|
-$3.78M |
| 3 |
Bank of New York Mellon
New York
|
-$2.76M |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$2.68M |
| 5 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
-$2.03M |
FLXN Hedge Fund Activity: Q3 2017 in Review
116 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q3 2017, worth a combined $660M — up 24% from $532M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new FLXN positions and 8 closed out — a net gain of 17 holders — while 34 added to existing stakes and 33 trimmed.
The largest buyer was Miller Value Partners, adding an estimated $15.4M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $7.18M.
- 116 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q3 2017, up from 100 in Q2 2017.
- Funds reported $660M of Flexion Therapeutics, Inc. stock for Q3 2017, up 24% quarter-over-quarter.
- 25 funds opened new Flexion Therapeutics, Inc. positions in Q3 2017 and 8 closed out, a net change of +17 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q3 2017 was Miller Value Partners, an estimated $15.4M added.
- The largest Flexion Therapeutics, Inc. seller in Q3 2017 was Gilder Gagnon Howe & Co, an estimated $7.18M sold.
Based on aggregated 13F filings for Q3 2017.